Jump Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Jump Financial’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-112	Closed	-$1.66K	–	2021
2024 Q3	$1.66K	Buy	+112	New	+$4.51K	﹤0.01%	1582

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jump Financial's TNXP Position: Q4 2024 in Review

Jump Financial sold out of Tonix Pharmaceuticals (TNXP) in Q4 2024, closing a stake of 112 shares — an estimated $1.66K sold.

Jump Financial first reported a position in TNXP in Q3 2024 and held it in 1 quarter. The position peaked at $1.66K in Q3 2024. 32 funds tracked by Wall St. Rank hold TNXP as of Q4 2024.

Jump Financial reported no remaining Tonix Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Jump Financial sold 112 Tonix Pharmaceuticals shares in Q4 2024, an estimated $1.66K.
Jump Financial first reported a position in Tonix Pharmaceuticals in Q3 2024 and held it in 1 quarter.
Jump Financial's Tonix Pharmaceuticals position peaked at $1.66K in Q3 2024.
32 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.